2017 AAPM Annual Meeting
Back to session list

Session Title: Recent Medical Physics Practice Guidelines and Your Delivery Path
Question 1: Which of these is the parent committee to SPG (i.e., is immediately above SPG in the AAPM organizational structure)?
Reference:http://www.aapm.org/org/structure/default.asp?committee_code=PICR
Choice A:Strategic Planning Committee.
Choice B:Administrative Council.
Choice C:Professional Council.
Choice D:Clinical Practice Committee.
Question 2: Which of the following is one of the SPG committee charges?
Reference:http://www.aapm.org/org/charges/spg.asp
Choice A:Edit clinical information in all Task Group reports.
Choice B:Evaluate scientific content of all Task Group reports.
Choice C:Evaluate all draft Task Group reports prior to publication, to determine whether a Clinical Implementation Guide would be appropriate and of benefit to AAPM members.
Choice D:To oversee AAPM activities which directly impact the practice environment. This includes interaction with corporate affiliates.
Question 3: Though the MPPG initiative started in 2011, in what year was SPG approved?
Reference:http://www.aapm.org/org/structure/default.asp?committee_code=SPG
Choice A:2007.
Choice B:2010.
Choice C:2013.
Choice D:2016.
Question 4: MPPG refers to:
Reference:AAPM Publications MPPG landing page: www.aapm.org/pubs/MPPG
Choice A:A Method for Procuring Protective Gear.
Choice B:The federal agency for radiological protection.
Choice C:Medical Physics Practice Guidelines, a series of guidelines developed by the AAPM to clearly define the minimum level of medical physics support for certain clinical services.
Choice D:Varian’s latest accelerator technology with Maximum Performance Per Gantry angle.
Choice E:The new Medicare reimbursement scheme.
Question 5: The intention of the MPPGs is to:
Reference:Chan MF, Prisciandaro JI, Shepard SJ, and Halvorsen PH. Medical Physics Practice Guidelines – the AAPM’s minimum practice recommendations for medical physicists. J Appl Clin Med Phys 14(6):1-4, 2013.
Choice A:Provide good practice recommendations for research.
Choice B:Replace traditional AAPM Task Group reports.
Choice C:Describe the minimum level of medical physics support the AAPM deems prudent in all clinical practice settings.
Choice D:Define residency program curriculum requirements.
Choice E:Create an official AAPM physics accreditation program.
Question 6: MPPGs are published:
Reference:AAPM Publications MPPG landing page: www.aapm.org/pubs/MPPG
Choice A:In the journal Medical Physics, available only to subscribers.
Choice B:As AAPM Monographs available from the AAPM by request.
Choice C:In the journal Medical Physics, designated as Open Access.
Choice D:In the open-access Journal of Applied Clinical Medical Physics.
Choice E:By the ACR.
Question 7: Personal Supervision means:
Reference:AAPM Professional Policy 18: www.aapm.org/org/policies/policy.asp?type=PP
Choice A:Supervising oneself
Choice B:The responsible professional defines the SOP for the procedure but does not need to be in the facility during patient procedures.
Choice C:The responsible professional defines the SOP for the procedure and monitors via CCTV or WebEx.
Choice D:The responsible professional has determined the competency of each staff.
Choice E:The responsible professional exercises General Supervision and is present in the room during the performance of the procedure.
Question 8: According to MPPG 5.a, planar or volumetric measurements for IMRT and VMAT commissioning should be evaluated with which gamma evaluation criterion?
Reference:Smilowitz, J. B., Das, I. J., Feygelman, V., Fraass, B. A., Kry, S. F., Marshall, I. R., Mihailidis, D. N., Ouhib, Z., Ritter, T., Snyder, M. G. and Fairobent, L. (2015), AAPM Medical Physics Practice Guideline 5.a.: Commissioning and QA of Treatment Planning Dose Calculations — Megavoltage Photon and Electron Beams. Journal of Applied Clinical Medical Physics, 16: 14–34. doi:10.1120/jacmp.v16i5.5768
Choice A:2%/2mm.
Choice B:3%/3mm.
Choice C:5%/3mm.
Choice D:The guideline makes no recommendation for evaluation criteria.
Question 9: Which of the following describes why using a stricter gamma criteria is valuable during commissioning?
Reference:Nelms, B. E., Chan, M. F., Jarry, G., Lemire, M., Lowden, J., Hampton, C. and Feygelman, V. (2013), Evaluating IMRT and VMAT dose accuracy: Practical examples of failure to detect systematic errors when applying a commonly used metric and action levels. Med. Phys., 40: n/a, 111722. doi:10.1118/1.4826166
Choice A:Stricter criteria can identify easily correctable modeling errors.
Choice B:Stricter criteria can highlight weaknesses in a dose calculation algorithm.
Choice C:Stricter criteria are more sensitive to changes in beam model parameters.
Choice D:All of the above.
Choice E:None of the above.
Question 10: After you have completed MPPG 5.a for a treatment machine, you may reuse your measured data to perform all of the following EXCEPT:
Reference:Jacqmin, D. J., Bredfeldt, J. S., Frigo, S. P. and Smilowitz, J. B. (2017), Implementation of the validation testing in MPPG 5.a “Commissioning and QA of treatment planning dose calculations–megavoltage photon and electron beams”. J Appl Clin Med Phys, 18: 115–127. doi:10.1002/acm2.12015
Choice A:Validation of a new treatment planning system for the same machine.
Choice B:Validation of a dose calculation algorithm after a treatment planning system software upgrade.
Choice C:Validation of a dose calculation model for a different treatment machine.
Choice D:Validation of a secondary check dose calculation algorithm for the same machine.
Back to session list